Abstract
The potential applications of superparamagnetic iron oxide nanoparticles (SPIONs) in several nanomedical fields have attracted intense interest based on the cell-nano interaction. However, the mechanisms underlying cell uptake, the intracellular trail, final fate and the biological effects of SPIONs have not yet been clearly elucidated. Here, we showed that multiple endocytic pathways were involved in the internalization process of SPIONs in the RAW264.7 macrophage. The internalized SPIONs were biocompatible and used three different metabolic pathways: The SPIONs were distributed to daughter cells during mitosis; they were degraded in the lysosome and free iron was released into the intracellular iron metabolic pool; and, the intact SPIONs were potentially exocytosed out of the cells. The internalized SPIONs did not induce cell damage but affected iron metabolism, inducing the upregulation of ferritin light chain at both the mRNA and protein levels and ferroportin 1 at the mRNA level. These results may contribute to the development of nanobiology and to the safe use of SPIONs in medicine when administered as a contrast medium or a drug delivery tool.
Article PDF
Similar content being viewed by others
References
Zhang K H, Guo L L, Cai Z, et al. Labeling efficiency and cell viability of human amniotic mesenchymal cells labeled with silica coated-superparamagnetic iron oxide nanoparticles. Sci Sin Vitae, 2010, 40: 1154–1160
Neri M, Maderna C, Cavazzin C, et al. Efficient in vitro labeling of human neural precursor cells with superparamagnetic iron oxide particles: relevance for in vivo cell tracking. Stem Cells, 2008, 26: 505–516, 17975226, 10.1634/stemcells.2007-0251, 1:CAS:528:DC%2BD1cXjt1Wls78%3D
Veiseh O, Gunn J W, Kievit F M, et al. Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles. Small, 2009, 5: 256–264, 19089837, 10.1002/smll.200800646, 1:CAS:528:DC%2BD1MXhvVWlsLo%3D
Johannsen M, Gneveckow U, Thiesen B, et al. Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution. Eur Urol, 2007, 52: 1653–1661, 17125906, 10.1016/j.eururo.2006.11.023
Jing X H, Yang L, Duan X J, et al. In vivo MR imaging tracking of magnetic iron oxide nanoparticle labeled, engineered, autologous bone marrow mesenchymal stem cells following intra-articular injection. Joint Bone Spine, 2008, 75: 432–438, 18448377, 10.1016/j.jbspin.2007.09.013
Neuwelt E A, Hamilton B E, Varallyay C G, et al. Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? Kidney Int, 2009, 75: 465–474, 18843256, 10.1038/ki.2008.496, 1:CAS:528:DC%2BD1MXit1Wntrw%3D
Huth S, Lausier J, Gersting S W, et al. Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J Gene Med, 2004, 6: 923–936, 15293351, 10.1002/jgm.577, 1:CAS:528:DC%2BD2cXnvFajsrw%3D
Mayor S, Pagano R E. Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell Biol, 2007, 8: 603–612, 17609668, 10.1038/nrm2216, 1:CAS:528:DC%2BD2sXotVahtrg%3D
Taylor P R, Martinez-Pomares L, Stacey M, et al. Macrophage receptors and immune recognition. Annu Rev Immunol, 2005, 23: 901–944, 15771589, 10.1146/annurev.immunol.23.021704.115816, 1:CAS:528:DC%2BD2MXktFOju7Y%3D
Lopez C F, Nielsen S O, Moore P B, et al. Understanding nature’s design for a nanosyringe. Proc Natl Acad Sci USA, 2004, 101: 4431–4434, 15070735, 10.1073/pnas.0400352101, 1:CAS:528:DC%2BD2cXjtFKju78%3D
Kostarelos K, Lacerda L, Pastorin G, et al. Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nat Nanotechnol, 2007, 2: 108–113, 18654229, 10.1038/nnano.2006.209, 1:CAS:528:DC%2BD2sXit1Wrtrs%3D
Davda J, Labhasetwar V. Characterization of nanoparticle uptake by endothelial cells. Int J Pharm, 2002, 233: 51–59, 11897410, 10.1016/S0378-5173(01)00923-1, 1:CAS:528:DC%2BD38XhslymsLg%3D
Kam N W, Liu Z, Dai H. Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway. Angew Chem Int Ed Engl, 2006, 45: 577–581, 16345107, 10.1002/anie.200503389, 1:CAS:528:DC%2BD28XpvVequg%3D%3D
Park J S, Han T H, Lee K Y, et al. N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release. J Control Release, 2006, 115: 37–45, 16935380, 10.1016/j.jconrel.2006.07.011, 1:CAS:528:DC%2BD28XpvVOht7c%3D
Arbab A S, Bashaw L A, Miller B R, et al. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology, 2003, 229: 838–846, 14657318, 10.1148/radiol.2293021215
Pawelczyk E, Arbab A S, Pandit S, et al. Expression of transferrin receptor and ferritin following ferumoxides-protamine sulfate labeling of cells: implications for cellular magnetic resonance imaging. NMR Biomed, 2006, 19: 581–592, 16673357, 10.1002/nbm.1038, 1:CAS:528:DC%2BD28XpsFejur8%3D
Corot C, Robert P, Idée J M, et al. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev, 2006, 58: 1471–1504, 17116343, 10.1016/j.addr.2006.09.013, 1:CAS:528:DC%2BD28Xht1KmtLbP
Libby P. Inflammation in atherosclerosis. Nature, 2002, 420: 868–874, 12490960, 10.1038/nature01323, 1:CAS:528:DC%2BD38XpsFygtb8%3D
Boyle J J. Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture. Curr Vasc Pharmacol, 2005, 3: 63–68, 15638783, 10.2174/1570161052773861, 1:CAS:528:DC%2BD2MXhvFOhsw%3D%3D
Nardin A, Abastado J P. Macrophages and cancer. Front Biosci, 2008, 13: 3494–3505, 18508451, 10.2741/2944, 1:CAS:528:DC%2BD1cXnsVKqtrY%3D
Molday R S. Magnetic iron-dextran microspheres. US Patent, No. 4452773, 1984
Fauconnier N, Bee A, Roger J, et al. Synthesis of aqueous magnetic liquids by surface complexation of maghemite nanoparticles. J Mol Liq, 1999, 83: 233–242, 10.1016/S0167-7322(99)00088-4
Goldstein J L, Anderson R G, Brown M S. Coated pits, coated vesicles, and receptor-mediated endocytosis. Nature, 1979, 279: 679–685, 221835, 10.1038/279679a0, 1:CAS:528:DyaL3cXhs1Og
Conner S D, Schmid S L. Regulated portals of entry into the cell. Nature, 2003, 422: 37–44, 12621426, 10.1038/nature01451, 1:CAS:528:DC%2BD3sXhs1yit7Y%3D
Takei K, Haucke V. Clathrin-mediated endocytosis: membrane factors pull the trigger. Trends Cell Biol, 2001, 11: 385–391, 11514193, 10.1016/S0962-8924(01)02082-7, 1:CAS:528:DC%2BD3MXmtV2gsLY%3D
Wang L H, Rothberg K G, Anderson R G. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol, 1993, 123: 1107–1117, 8245121, 10.1083/jcb.123.5.1107, 1:CAS:528:DyaK3sXmsVKkt70%3D
Elferink J G. Chlorpromazine inhibits phagocytosis and exocytosis in rabbit polymorphonuclear leukocytes. Biochem Pharmacol, 1979, 28: 965–968, 375938, 10.1016/0006-2952(79)90287-9, 1:CAS:528:DyaE1MXmtVChsb8%3D
Watanabe S, Hirose M, Miyazaki A, et al. Calmodulin antagonists inhibit the phagocytic activity of cultured Kupffer cells. Lab Invest, 1988, 59: 214–218, 3404973, 1:CAS:528:DyaL1cXlsVKrtL8%3D
Lajoie P, Nabi I R. Regulation of raft-dependent endocytosis. J Cell Mol Med, 2007, 11: 644–653, 17760830, 10.1111/j.1582-4934.2007.00083.x, 1:CAS:528:DC%2BD2sXhtFSksrnE
Kitajima Y, Sekiya T, Nozawa Y. Freeze-fracture ultrastructural alterations induced by filipin, pimaricin, nystatin and amphotericin B in the plasmia membranes of Epidermophyton, Saccharomyces and red complex-induced membrane lesions. Biochim Biophys Acta, 1976, 455: 452–465, 793632, 10.1016/0005-2736(76)90317-5, 1:CAS:528:DyaE2sXltVGgug%3D%3D
Kilsdonk E P, Yancey P G, Stoudt G W. Cellular cholesterol efflux mediated by cyclodextrins. J Biol Chem, 1995, 270: 17250–17256, 7615524, 10.1074/jbc.270.29.17250, 1:CAS:528:DyaK2MXntVOrtr4%3D
Kwik J, Boyle S, Fooksman D, et al. Membrane cholesterol, lateral mobility, and the phosphatidylinositol 4,5-bisphosphate-dependent organization of cell actin. Proc Natl Acad Sci USA, 2003, 100: 13964–13969, 14612561, 10.1073/pnas.2336102100, 1:CAS:528:DC%2BD3sXpsFGisbY%3D
Qualmann B, Kessels M M, Kelly R B. Molecular links between endocytosis and the actin cytoskeleton. J Cell Biol, 2000, 150: F111–F116, 10974009, 10.1083/jcb.150.5.F111, 1:CAS:528:DC%2BD3cXmtlegtrc%3D
Raynal I, Prigent P, Peyramaure S, et al. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol, 2004, 39: 56–63, 14701989, 10.1097/01.rli.0000101027.57021.28, 1:CAS:528:DC%2BD2cXhtFSj
Harush-Frenkel O, Debotton N, Benita S, et al. Targeting of nanoparticles to the clathrin-mediated endocytic pathway. Biochem Biophys Res Commun, 2007, 353: 26–32, 17184736, 10.1016/j.bbrc.2006.11.135, 1:CAS:528:DC%2BD2sXht1Sgtg%3D%3D
Jones A T. Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides. J Cell Mol Med, 2007, 11: 670–684, 17760832, 10.1111/j.1582-4934.2007.00062.x, 1:CAS:528:DC%2BD2sXhtFSksrbO
West M A, Bretscher M S, Watts C. Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells. J Cell Biol, 1989, 109: 2731–2739, 2556406, 10.1083/jcb.109.6.2731, 1:CAS:528:DyaL1MXmt1Gqsbc%3D
Kaksonen M, Toret C P, Drubin D G. Harnessing actin dynamics for clathrin mediated endocytosis. Nat Rev Mol Cell Biol, 2006, 7: 404–414, 16723976, 10.1038/nrm1940, 1:CAS:528:DC%2BD28XkvVylsbw%3D
Merrifield C J. Seeing is believing: imaging actin dynamics at single sites of endocytosis. Trends Cell Biol, 2004, 14: 352–358, 15246428, 10.1016/j.tcb.2004.05.008, 1:CAS:528:DC%2BD2cXls1Wkurk%3D
Wang S W, Yang C S, Chen Y C. The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles. Biomaterials, 2009, 30: 3645–3651, 19359036, 10.1016/j.biomaterials.2009.03.032
Skotland T, Sontum P C, Oulie I. In vitro stability analyses as a model for metabolism of ferromagnetic particles (Clariscan), a contrast agent for magnetic resonance imaging. J Pharm Biomed Anal, 2002, 28: 323–329, 11929675, 10.1016/S0731-7085(01)00592-1, 1:CAS:528:DC%2BD38XisFWnsLg%3D
Arbab A S, Wilson L B, Ashari P, et al. A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging. NMR Biomed, 2005, 18: 383–389, 16013087, 10.1002/nbm.970, 1:CAS:528:DC%2BD2MXhtF2nsbbO
Jin H, Heller D A, Strano M S. Single-particle tracking of endocytosis and exocytosis of single-walled carbon nanotubes in NIH-3T3 cells. Nano Lett, 2008, 8: 1577–1585, 18491944, 10.1021/nl072969s
Pouliquen D, Le Jeune J J, Perdrisot R, et al. Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism. Magn Reson Imaging, 1991, 9: 275–283, 1881245, 10.1016/0730-725X(91)90412-F, 1:CAS:528:DyaK3MXlslyhtbw%3D
Okon E, Pouliquen D, Okon P, et al. Biodegradation of magnetite dextran nanoparticles in the rat. A histologic and biophysical study. Lab Invest, 1994, 71: 895–903, 7807971, 1:CAS:528:DyaK2MXjs12gsbg%3D
Hentze M W, Muckenthaler M U, Andrews N C. Balancing acts: molecular control of mammalian iron metabolism. Cell, 2004, 117: 285–297, 15109490, 10.1016/S0092-8674(04)00343-5, 1:CAS:528:DC%2BD2cXjvFemsbg%3D
Coulson R M, Cleveland D W. Ferritin synthesis is controlled by iron-dependent translational derepression and by changes in synthesis/transport of nuclear ferritin RNAs. Proc Natl Acad Sci USA, 1993, 90: 7613–7617, 8356063, 10.1073/pnas.90.16.7613, 1:CAS:528:DyaK3sXlslyisLY%3D
Liu X B, Hill P, Haile D J. Role of the ferroportin iron-responsive element in iron and nitric oxide dependent gene regulation. Blood Cells Mol Dis, 2002, 29: 315–326, 12547222, 10.1006/bcmd.2002.0572, 1:CAS:528:DC%2BD3sXlt1yluw%3D%3D
Aydemir F, Jenkitkasemwong S, Gulec S, et al. Iron loading increases ferroportin heterogeneous nuclear RNA and mRNA levels in murine J774 macrophages. J Nutr, 2009, 139: 434–438, 19141705, 10.3945/jn.108.094052, 1:CAS:528:DC%2BD1MXjsFKitLk%3D
Eisenstein R S. Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu Rev Nutr, 2000, 20: 627–662, 10940348, 10.1146/annurev.nutr.20.1.627, 1:CAS:528:DC%2BD3cXmsVKls7w%3D
Yuan X M, Li W, Baird S K, et al. Secretion of ferritin by iron-laden macrophages and influence of lipoproteins. Free Radic Res, 2004, 38: 1133–1142, 15512802, 10.1080/10715760400011692, 1:CAS:528:DC%2BD2cXptFKqu7k%3D
Leimberg M J, Prus E, Konijn A M, et al. Macrophages function as a ferritin iron source for cultured human erythroid precursors. J Cell Biochem, 2008, 103: 1211–1218, 17902167, 10.1002/jcb.21499, 1:CAS:528:DC%2BD1cXjtVyntb0%3D
Author information
Authors and Affiliations
Corresponding authors
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://creativecommons.org/licenses/by-nc/2.0), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
About this article
Cite this article
Gu, J., Xu, H., Han, Y. et al. The internalization pathway, metabolic fate and biological effect of superparamagnetic iron oxide nanoparticles in the macrophage-like RAW264.7 cell. Sci. China Life Sci. 54, 793–805 (2011). https://doi.org/10.1007/s11427-011-4215-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-011-4215-5